Antacid therapy in idiopathic pulmonary fibrosis: more questions than answers?

  • Kerri A Johannson, Irina Strâmbu, Claudia Ravaglia, Jan C Grutters, Claudia Valenzuela, Nesrin Mogulkoc, Fabrizio Luppi, Luca Richeldi, Athol U Wells, Carlo Vancheri, Michael Kreuter, Carlo Albera, Katerina M. Antoniou, Goksel Altinisik, Elisabeth Bendstrup, Benjamin Bondue, Raphael Borie, Kevin K. Brown, Philippe Camus, Diego Castillo, Harold R. Collard, Vincent Cottin, Nunzio Crimi, Giovanni Ferrara, Aryeh Fischer, Jack Gauldie, Thomas Geiser, Andreas Guenther, Nathan Hambly, David M. Hansell, Sergio Harari, Mark G. Jones, Michael Keane, Brett Ley, Toby M. Maher, Maria Molina-Molina, Stefano Palmucci, Venerino Poletti, Antje Prasse, Paola Rottoli, Paolo Spagnolo, Martina Sterclova, Sebastiano Torrisi, Eliza Tsitoura, Martina Vasakova, Simon L. Walsh, Marlies S. Wijsenbeek, Wim A. Wuyts
  • The Lancet Respiratory Medicine, July 2017, Elsevier
  • DOI: 10.1016/s2213-2600(17)30219-9

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1016/s2213-2600(17)30219-9

The following have contributed to this page: Dr Giovanni Ferrara